{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T00:53:55Z","timestamp":1791075235547,"version":"4.1.0"},"reference-count":43,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"9","funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["202904\/Z\/16\/Z"],"award-info":[{"award-number":["202904\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["206181\/Z\/17\/Z"],"award-info":[{"award-number":["206181\/Z\/17\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004682","name":"Oracle","doi-asserted-by":"publisher","award":["Oracle Higher Education and Research programme"],"award-info":[{"award-number":["Oracle Higher Education and Research programme"]}],"id":[{"id":"10.13039\/100004682","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome","doi-asserted-by":"publisher","award":["210701\/Z\/18\/Z"],"award-info":[{"award-number":["210701\/Z\/18\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["279039"],"award-info":[{"award-number":["279039"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"BBSRC","doi-asserted-by":"crossref","award":["BB\/L01386X\/1"],"award-info":[{"award-number":["BB\/L01386X\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000266","name":"EPSRC","doi-asserted-by":"crossref","award":["EP\/R013764\/1"],"award-info":[{"award-number":["EP\/R013764\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000266","name":"EPSRC","doi-asserted-by":"crossref","award":["EP\/N018591\/1"],"award-info":[{"award-number":["EP\/N018591\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000268","name":"BBSRC","doi-asserted-by":"crossref","award":["BB\/P000940\/1"],"award-info":[{"award-number":["BB\/P000940\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000268","name":"BBSRC","doi-asserted-by":"crossref","award":["BB\/R000484\/1"],"award-info":[{"award-number":["BB\/R000484\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-INSB-05-02"],"award-info":[{"award-number":["ANR-10-INSB-05-02"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-LABX-49-01"],"award-info":[{"award-number":["ANR-10-LABX-49-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sci. Adv."],"published-print":{"date-parts":[[2019,9,6]]},"abstract":"<jats:p>ADDomer is a synthetic, self-assembling, virus-like particle platform that enables highly efficient vaccination.<\/jats:p>","DOI":"10.1126\/sciadv.aaw2853","type":"journal-article","created":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T23:23:53Z","timestamp":1569540233000},"source":"Crossref","is-referenced-by-count":45,"title":["Synthetic self-assembling ADDomer platform for highly efficient vaccination by genetically encoded multiepitope display"],"prefix":"10.1126","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4863-7209","authenticated-orcid":true,"given":"Charles","family":"Vragniau","sequence":"first","affiliation":[{"name":"Institut de Biologie Structurale (IBS), Universit\u00e9 Grenoble Alpes, CNRS, CEA, 71 Avenue des Martyrs, 38042 Grenoble, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6891-6515","authenticated-orcid":true,"given":"Joshua C.","family":"Bufton","sequence":"additional","affiliation":[{"name":"Bristol Research Centre for Synthetic Biology BrisSynBio, School of Biochemistry, University of Bristol, 1 Tankard\u2019s Close, Bristol BS8 1TD, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Garzoni","sequence":"additional","affiliation":[{"name":"Imophoron Ltd., Unit DX, St. Philips Central, Albert Road, Bristol BS2 OXJ, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Stermann","sequence":"additional","affiliation":[{"name":"Institut de Biologie Structurale (IBS), Universit\u00e9 Grenoble Alpes, CNRS, CEA, 71 Avenue des Martyrs, 38042 Grenoble, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fruzsina","family":"Rabi","sequence":"additional","affiliation":[{"name":"Bristol Research Centre for Synthetic Biology BrisSynBio, School of Biochemistry, University of Bristol, 1 Tankard\u2019s Close, Bristol BS8 1TD, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6139-4072","authenticated-orcid":true,"given":"C\u00e9line","family":"Terrat","sequence":"additional","affiliation":[{"name":"Laboratoire de Biologie Tissulaire et d'Ing\u00e9nierie Th\u00e9rapeutique (LBTI), UMR 5305, Universit\u00e9 Lyon 1, CNRS, Institut de Biologie et Chimie des Prot\u00e9ines (IBCP), Lyon, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6733-3801","authenticated-orcid":true,"given":"M\u00e9lanie","family":"Guidetti","sequence":"additional","affiliation":[{"name":"Cancer Target and Experimental Therapeutics, Institute for Advanced Biosciences, INSERM U1209, CNRS UMR5309, Universit\u00e9 Grenoble Alpes, 38700 Grenoble, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6733-3801","authenticated-orcid":true,"given":"V\u00e9ronique","family":"Josserand","sequence":"additional","affiliation":[{"name":"Cancer Target and Experimental Therapeutics, Institute for Advanced Biosciences, INSERM U1209, CNRS UMR5309, Universit\u00e9 Grenoble Alpes, 38700 Grenoble, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2198-1058","authenticated-orcid":true,"given":"Matt","family":"Williams","sequence":"additional","affiliation":[{"name":"Advanced Computing Research Centre, University of Bristol, 31 Great George Street, Bristol BS1 5QD, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Woods","sequence":"additional","affiliation":[{"name":"Advanced Computing Research Centre, University of Bristol, 31 Great George Street, Bristol BS1 5QD, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3626-4836","authenticated-orcid":true,"given":"Gerardo","family":"Viedma","sequence":"additional","affiliation":[{"name":"Oracle Cloud Development Centre, Tower Wharf, Cheese Lane, Bristol BS2 2JJ, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6010-1151","authenticated-orcid":true,"given":"Phil","family":"Bates","sequence":"additional","affiliation":[{"name":"Oracle Cloud Development Centre, Tower Wharf, Cheese Lane, Bristol BS2 2JJ, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Verrier","sequence":"additional","affiliation":[{"name":"Laboratoire de Biologie Tissulaire et d'Ing\u00e9nierie Th\u00e9rapeutique (LBTI), UMR 5305, Universit\u00e9 Lyon 1, CNRS, Institut de Biologie et Chimie des Prot\u00e9ines (IBCP), Lyon, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1479-9410","authenticated-orcid":true,"given":"Laurence","family":"Chaperot","sequence":"additional","affiliation":[{"name":"Immunobiology and Immunotherapy in Chronic Diseases, Institute for Advanced Biosciences, INSERM U1209, CNRS UMR5309, Universit\u00e9 Grenoble Alpes, Etablissement Fran\u00e7ais du Sang-Rhone-Alpes, 38700 Grenoble, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1516-9760","authenticated-orcid":true,"given":"Christiane","family":"Schaffitzel","sequence":"additional","affiliation":[{"name":"Bristol Research Centre for Synthetic Biology BrisSynBio, School of Biochemistry, University of Bristol, 1 Tankard\u2019s Close, Bristol BS8 1TD, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7518-9045","authenticated-orcid":true,"given":"Imre","family":"Berger","sequence":"additional","affiliation":[{"name":"Bristol Research Centre for Synthetic Biology BrisSynBio, School of Biochemistry, University of Bristol, 1 Tankard\u2019s Close, Bristol BS8 1TD, UK."},{"name":"Max Planck-Bristol Centre for Minimal Biology, Cantock\u2019s Close, Bristol BS8 1TS, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6698-3367","authenticated-orcid":true,"given":"Pascal","family":"Fender","sequence":"additional","affiliation":[{"name":"Institut de Biologie Structurale (IBS), Universit\u00e9 Grenoble Alpes, CNRS, CEA, 71 Avenue des Martyrs, 38042 Grenoble, France."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.3389\/fimmu.2018.01432","article-title":"New routes and opportunities for modular construction of particulate vaccines: Stick, click, and glue","volume":"9","author":"Brune K. D.","year":"2018","unstructured":"K. D. Brune, M. Howarth, New routes and opportunities for modular construction of particulate vaccines: Stick, click, and glue. Front. Immunol. 9, 1432 (2018).","journal-title":"Front. Immunol."},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.coviro.2016.03.001","article-title":"Engineering virus-like particles as vaccine platforms","volume":"18","author":"Frietze K. M.","year":"2016","unstructured":"K. M. Frietze, D. S. Peabody, B. Chackerian, Engineering virus-like particles as vaccine platforms. Curr. Opin. Virol. 18, 44\u201349 (2016).","journal-title":"Curr. Opin. Virol."},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.tibtech.2015.02.007","article-title":"Towards protein-based viral mimetics for cancer therapies","volume":"33","author":"Unzueta U.","year":"2015","unstructured":"U. Unzueta, M. V. C\u00e9spedes, E. V\u00e1zquez, N. F. Miralles, R. Mangues, A. Villaverde, Towards protein-based viral mimetics for cancer therapies. Trends Biotechnol. 33, 253\u2013258 (2015).","journal-title":"Trends Biotechnol."},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"E370","DOI":"10.3390\/genes9070370","article-title":"Bioengineering strategies for protein-based nanoparticles","volume":"9","author":"Diaz D.","year":"2018","unstructured":"D. Diaz, A. Care, A. Sunna, Bioengineering strategies for protein-based nanoparticles. Genes 9, E370 (2018).","journal-title":"Genes"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri2868"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.coviro.2013.05.004","article-title":"Virus-induced humoral immunity: On how B cell responses are initiated","volume":"3","author":"Zabel F.","year":"2013","unstructured":"F. Zabel, T. M. K\u00fcndig, M. F. Bachmann, Virus-induced humoral immunity: On how B cell responses are initiated. Curr. Opin. Virol. 3, 357\u2013362 (2013).","journal-title":"Curr. Opin. Virol."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2012.61"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-015-0350-4"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.nbt.2017.07.010","article-title":"Production of virus-like particles for vaccines","volume":"39","author":"Fuenmayor J.","year":"2017","unstructured":"J. Fuenmayor, F. G\u00f2dia, L. Cervera, Production of virus-like particles for vaccines. N. Biotechnol. 39, 174\u2013180 (2017).","journal-title":"N. Biotechnol."},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2240"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.vaccine.2013.02.001","article-title":"Active immunotherapy for chronic diseases","volume":"31","author":"Bachmann M. F.","year":"2013","unstructured":"M. F. Bachmann, P. Whitehead, Active immunotherapy for chronic diseases. Vaccine 31, 1777\u20131784 (2013).","journal-title":"Vaccine"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1016\/j.vaccine.2016.08.045","article-title":"Improving cold chain systems: Challenges and solutions","volume":"35","author":"Ashok A.","year":"2016","unstructured":"A. Ashok, M. Brison, Y. LeTallec, Improving cold chain systems: Challenges and solutions. Vaccine 35, 2217\u20132223 (2016).","journal-title":"Vaccine"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/hum.2013.2527","article-title":"Adenovirus: The first effective in vivo gene delivery vector","volume":"25","author":"Crystal R. G.","year":"2014","unstructured":"R. G. Crystal, Adenovirus: The first effective in vivo gene delivery vector. Hum. Gene Ther. 25, 3\u201311 (2014).","journal-title":"Hum. Gene Ther."},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/0042-6822(66)90165-6","article-title":"The relationship between the soluble antigens and the virion of adenovirus type 3. II. Identification and characterization of an incomplete hemagglutinin","volume":"30","author":"Norrby E.","year":"1966","unstructured":"E. Norrby, The relationship between the soluble antigens and the virion of adenovirus type 3. II. Identification and characterization of an incomplete hemagglutinin. Virology 30, 608\u2013617 (1966).","journal-title":"Virology"},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nbt0197-52","article-title":"Adenovirus dodecahedron, a new vector for human gene transfer","volume":"15","author":"Fender P.","year":"1997","unstructured":"P. Fender, R. W. Ruigrok, E. Gout, S. Buffet, J. Chroboczek, Adenovirus dodecahedron, a new vector for human gene transfer. Nat. Biotechnol. 15, 52\u201356 (1997).","journal-title":"Nat. Biotechnol."},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.virol.2005.06.030","article-title":"Synthesis, cellular localization, and quantification of penton-dodecahedron in serotype 3 adenovirus-infected cells","volume":"340","author":"Fender P.","year":"2005","unstructured":"P. Fender, A. Boussaid, P. Mezin, J. Chroboczek, Synthesis, cellular localization, and quantification of penton-dodecahedron in serotype 3 adenovirus-infected cells. Virology 340, 167\u2013173 (2005).","journal-title":"Virology"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"e46075","DOI":"10.1371\/journal.pone.0046075","article-title":"The structural basis for the integrity of adenovirus Ad3 dodecahedron","volume":"7","author":"Szolajska E.","year":"2012","unstructured":"E. Szolajska, W. P. Burmeister, M. Zochowska, B. Nerlo, I. Andreev, G. Schoehn, J. P. Andrieu, P. Fender, A. Naskalska, C. Zubieta, S. Cusack, J. Chroboczek, The structural basis for the integrity of adenovirus Ad3 dodecahedron. PLOS ONE. 7, e46075 (2012).","journal-title":"PLOS ONE."},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"5030589","DOI":"10.1155\/2016\/5030589","article-title":"The use of adenovirus dodecahedron in the delivery of an enzymatic activity in the cell","volume":"2016","author":"Sumarheni","year":"2016","unstructured":"Sumarheni, B. Gallet, P. Fender, The use of adenovirus dodecahedron in the delivery of an enzymatic activity in the cell. Biotechnol. Res. Int. 2016, 5030589 (2016).","journal-title":"Biotechnol. Res. Int."},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/mt.2010.16","article-title":"In vivo delivery of antigens by adenovirus dodecahedron induces cellular and humoral immune responses to elicit antitumor immunity","volume":"18","author":"Villegas-Mendez A.","year":"2010","unstructured":"A. Villegas-Mendez, M. I. Garin, E. Pineda-Molina, E. Veratti, J. A. Bueren, P. Fender, J. L. Lenormand, In vivo delivery of antigens by adenovirus dodecahedron induces cellular and humoral immune responses to elicit antitumor immunity. Mol. Ther. 18, 1046\u20131053 (2010).","journal-title":"Mol. Ther."},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"7385","DOI":"10.1016\/j.vaccine.2009.09.021","article-title":"Influenza recombinant vaccine: Matrix protein M1 on the platform of the adenovirus dodecahedron","volume":"27","author":"Naskalska A.","year":"2009","unstructured":"A. Naskalska, E. Szolajska, L. Chaperot, J. Angel, J. Plumas, J. Chroboczek, Influenza recombinant vaccine: Matrix protein M1 on the platform of the adenovirus dodecahedron. Vaccine 27, 7385\u20137393 (2009).","journal-title":"Vaccine"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"541939","DOI":"10.1155\/2010\/541939","article-title":"The adenovirus type 3 dodecahedron\u2019s RGD loop comprises an HSPG binding site that influences integrin binding","volume":"2010","author":"Gout E.","year":"2010","unstructured":"E. Gout, G. Schoehn, D. Fenel, H. Lortat-Jacob, P. Fender, The adenovirus type 3 dodecahedron\u2019s RGD loop comprises an HSPG binding site that influences integrin binding. J. Biomed. Biotechnol. 2010, 541939 (2010).","journal-title":"J. Biomed. Biotechnol."},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1754-1611-2-5","article-title":"Engineering BioBrick vectors from BioBrick parts","volume":"2","author":"Shetty R. P.","year":"2008","unstructured":"R. P. Shetty, D. Endy, T. F. Knight Jr., Engineering BioBrick vectors from BioBrick parts. J. Biol. Eng. 2, 5 (2008).","journal-title":"J. Biol. Eng."},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/978-3-319-27216-0_13","article-title":"The multibac baculovirus\/insect cell expression vector system for producing complex protein biologics","volume":"896","author":"Sari D.","year":"2016","unstructured":"D. Sari, K. Gupta, D. B. Thimiri-Govinda-Raj, A. Aubert, P. Drncov\u00e1, F. Garzoni, D. Fitzgerald, I. Berger, The multibac baculovirus\/insect cell expression vector system for producing complex protein biologics. Adv. Exp. Med. Biol. 896, 199\u2013215 (2016).","journal-title":"Adv. Exp. Med. Biol."},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/emmm.201200213"},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"12360","DOI":"10.1073\/pnas.1510533112","article-title":"Assessing sequence plasticity of a virus-like nanoparticle by evolution toward a versatile scaffold for vaccines and drug delivery","volume":"112","author":"Lu Y.","year":"2015","unstructured":"Y. Lu, W. Chan, B. Y. Ko, C. C. VanLang, J. R. Swartz, Assessing sequence plasticity of a virus-like nanoparticle by evolution toward a versatile scaffold for vaccines and drug delivery. Proc. Natl. Acad. Sci. U.S.A. 112, 12360\u201312365 (2015).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2011.10.005"},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"5.20.1","DOI":"10.1002\/0471140864.ps0520s51","article-title":"MultiBac: Multigene baculovirus-based eukaryotic protein complex production","volume":"51","author":"Bieniossek C.","year":"2008","unstructured":"C. Bieniossek, T. J. Richmond, I. Berger, MultiBac: Multigene baculovirus-based eukaryotic protein complex production. Curr. Protoc. Protein Sci. 51, 5.20.1\u20135.20.26 (2008).","journal-title":"Curr. Protoc. Protein Sci."},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1107\/S0907444911036225","article-title":"A thermal stability assay can help to estimate the crystallization likelihood of biological samples","volume":"67","author":"Dupeux F.","year":"2011","unstructured":"F. Dupeux, M. R\u00f6wer, G. Seroul, D. Blot, J. A. M\u00e1rquez, A thermal stability assay can help to estimate the crystallization likelihood of biological samples. Acta Crystallogr. Sect. D Biol. Crystallogr. 67, 915\u2013919 (2011).","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsb.2012.09.006"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.2472"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1047-8477(03)00069-8"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2003.07.013"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-40"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1107\/S0907444904019158"},{"key":"e_1_3_2_36_2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1107\/S2059798318006551","article-title":"Real-space refinement in Phenix for cryo-EM and crystallography","volume":"74","author":"Afonine P. V.","year":"2018","unstructured":"P. V. Afonine, B. K. Poon, R. J. Read, O. V. Sobolev, T. C. Terwilliger, A. Urzhumtsev, P. D. Adams, Real-space refinement in Phenix for cryo-EM and crystallography. Acta Crystallogr. Sect. D Biol. Crystallogr. 74, 531\u2013544 (2018).","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1107\/S0907444909042073"},{"key":"e_1_3_2_38_2","doi-asserted-by":"crossref","first-page":"5781","DOI":"10.4049\/jimmunol.1402184","article-title":"Cutting edge: New chimeric NOD2\/TLR2 adjuvant drastically increases vaccine immunogenicity","volume":"193","author":"Pavot V.","year":"2014","unstructured":"V. Pavot, N. Rochereau, J. Ress\u00e9guier, A. Gutjahr, C. Genin, G. Tiraby, E. Perouzel, T. Lioux, F. Vernejoul, B. Verrier, S. Paul, Cutting edge: New chimeric NOD2\/TLR2 adjuvant drastically increases vaccine immunogenicity. J. Immunol. 193, 5781\u20135785 (2014).","journal-title":"J. Immunol."},{"key":"e_1_3_2_39_2","doi-asserted-by":"crossref","first-page":"6060","DOI":"10.1016\/j.biomaterials.2010.04.021","article-title":"Traffic of poly(lactic acid) nanoparticulate vaccine vehicle from intestinal mucus to sub-epithelial immune competent cells","volume":"31","author":"Primard C.","year":"2010","unstructured":"C. Primard, N. Rochereau, E. Luciani, C. Genin, T. Delair, S. Paul, B. Verrier, Traffic of poly(lactic acid) nanoparticulate vaccine vehicle from intestinal mucus to sub-epithelial immune competent cells. Biomaterials 31, 6060\u20136068 (2010).","journal-title":"Biomaterials"},{"key":"e_1_3_2_40_2","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pep.2015.05.009","article-title":"A purified truncated form of yeast Gal4 expressed in Escherichia coli and used to functionalize poly(lactic acid) nanoparticle surface is transcriptionally active in cellulo","volume":"113","author":"Legaz S.","year":"2015","unstructured":"S. Legaz, J.-Y. Exposito, A. Borel, M. P. Candusso, S. Megy, R. Montserret, V. Lahaye, C. Terzian, B. Verrier, A purified truncated form of yeast Gal4 expressed in Escherichia coli and used to functionalize poly(lactic acid) nanoparticle surface is transcriptionally active in cellulo. Protein Expr. Purif. 113, 94\u2013101 (2015).","journal-title":"Protein Expr. Purif."},{"key":"e_1_3_2_41_2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.30750\/ijpbr.2.4.10","article-title":"In silico modeling and immunoinformatics probing disclose the epitope based peptide vaccine against zika virus envelope glycoprotein","volume":"2","author":"Shawan M. M. A. K.","year":"2014","unstructured":"M. M. A. K. Shawan, H. A. Mahmud, M. Hasan, A. Parvin, N. Rahman, S. M. B. Rahman, In silico modeling and immunoinformatics probing disclose the epitope based peptide vaccine against zika virus envelope glycoprotein. Indian J. Pharm. Biol. Res. 2, 44\u201357 (2014).","journal-title":"Indian J. Pharm. Biol. Res."},{"key":"e_1_3_2_42_2","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1128\/JCM.00187-08","article-title":"Variation of a newcastle disease virus hemagglutinin-neuraminidase linear epitope","volume":"46","author":"Cho S.-H.","year":"2008","unstructured":"S.-H. Cho, H.-J. Kwon, T.-E. Kim, J.-H. Kim, H.-S. Yoo, S.-J. Kim, Variation of a newcastle disease virus hemagglutinin-neuraminidase linear epitope. J. Clin. Microbiol. 46, 1541\u20131544 (2008).","journal-title":"J. Clin. Microbiol."},{"key":"e_1_3_2_43_2","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1016\/j.vaccine.2007.03.018","article-title":"Development of a multi-mimotope peptide as a vaccine immunogen for infectious bursal disease virus","volume":"25","author":"Wang Y.-S.","year":"2007","unstructured":"Y.-S. Wang, H.-J. Fan, Y. Li, Z.-L. Shi, Y. Pan, C.-P. Lu, Development of a multi-mimotope peptide as a vaccine immunogen for infectious bursal disease virus. Vaccine 25, 4447\u20134455 (2007).","journal-title":"Vaccine"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2004.11.041"}],"container-title":["Science Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/sciadv.aaw2853","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T16:23:08Z","timestamp":1704817388000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/sciadv.aaw2853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,6]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9,6]]}},"alternative-id":["10.1126\/sciadv.aaw2853"],"URL":"https:\/\/doi.org\/10.1126\/sciadv.aaw2853","relation":{},"ISSN":["2375-2548"],"issn-type":[{"value":"2375-2548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,6]]},"article-number":"eaaw2853"}}